← All trials
NCT03812263
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2018
- Primary completion
- Nov 30, 2022
- Completion date
- Feb 28, 2023
- First posted
- —
- Last posted
- —
- Enrollment
- 9
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Rocket Pharma LimitedLead sponsor
- California Institute for Regenerative Medicine (CIRM)Collaborator
- Hospital Infantil Universitario Niño JesúsOverall official - principal investigator
- University of California, Los AngelesOfficial
- Hospital Infantil Universitario Niño JesúsOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.